Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of BKM120 or BEZ235 and Capecitabine in Patients With Metastatic Breast Cancer
This study is currently recruiting participants.
Verified February 2013 by UNC Lineberger Comprehensive Cancer Center
Study NCT01300962   Information provided by UNC Lineberger Comprehensive Cancer Center

First Received on February 17, 2011.   Last Updated on February 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
BMK120
Capecitabine
BEZ235
Additional drug interventions recognized in this trial
Fluorouracil
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
UNC Lineberger Comprehensive Cancer Center
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services